ANTI YAL 5X1500UI

ANTI YAL 5x1500UI is characterised by:
- Hyaluronidase with the following posology: 1500 IU of powder extract per ampoule to be diluted in 10 ml of saline solution.
- Single-use vials of lyophilised powder.
- Injection acting on the degradation of hyaluronic acid.
- Liquid formulation for injections.

- XCELENS
- NAME: ANTI YAL
- COMPOSITION: Contains hyaluronidase with the following dosage: 1500 IU of powder extract per ampoule to be diluted in 10 ml of saline solution.
- PRESENTATION: 5 vials with 1500IU of hyaluronidase each.
- INDICATIONS: Corrects unsatisfactory results of previous treatments with hyaluronic acid. Hyaluronidase reduces fibrosis. Reduces the appearance of hypertrophic scars. Increases the absorption of other products.
- INJECTION DEPTH: Generally, the injection is made into the superficial or middle dermis to ensure effective action on the injected substance.
- DURATION: The effect starts from the first application to 48 hours, and may last up to 14 days afterwards, depending on the type of hyaluronic acid in the filler.
- USE: Strict medical use.

- Vials: 5 x 1500 IU hyaluronidase.
- Each box contains 5 vials x 1500 IU of lyophilised ANTI YAL powder for single use and sterile.

Application of the product should be limited to the affected area only. ANTI YAL 5x1500UI should be applied to areas where previous treatments have been carried out; it serves to resolve complications from thrombosis, reduces fibrosis. It can be applied on hypertrophic scars and for the absorption of other products.

- Hyaluronidase.

The use of ANTI YAL 5x1500UI requires the following precautions:
- Professional use only: the product should only be administered by qualified medical personnel experienced in hyaluronidase injection techniques.
- Preliminary medical assessment: a careful medical history is required before treatment to rule out allergies or conditions that may increase the risk of adverse reactions.
- Correct injection technique: administration must take place in the dermis or subcutaneous tissue, with sterile and appropriate instruments to avoid complications such as infection, haematoma or local reactions.
- Post-treatment monitoring: observe the patient over the next few hours for any allergic reactions or side effects.
- Avoid use in inflamed or injured areas: to prevent infectious or irritative complications.
- Do not exceed recommended doses: to minimise the risk of systemic adverse reactions.
- Inform the patient: clearly explain the objectives of the treatment, possible side effects and post-procedure care.
- Avoid concomitant treatment: avoid concomitant use with other fillers or drugs in the same area until treatment with ANTI YAL 5x1500UI is complete.

The use of ANTI YAL 5x1500UI is contraindicated in the following cases:
- Allergy to product components: contraindicated in case of known hypersensitivity to hyaluronidase or any of the excipients in the formulation.
- Infection or inflammation in the treatment area: do not administer in skin areas with infection, active inflammation or open lesions.
- Pregnancy and lactation: treatment is not recommended during pregnancy or lactation, as there are insufficient data available on the safety of the product under these conditions.
- Bleeding disorders or use of anticoagulants: may increase the risk of bleeding, bruising or haematomas.
- Presence of tumours or malignant skin diseases in the area to be treated: use is contraindicated in such cases.
- Under 18 years of age: safety and efficacy have not been established in minors.
- Previous allergic reactions to hyaluronidase treatment: the product should not be used in patients with a history of allergic reactions to this enzyme class.

ANTI YAL 5x1500UI Corrects unsatisfactory results of previous hyaluronic acid treatments e.g. hypercorrection, asymmetry, Tyndall effect, oedema under the eyelid that usually remains for a long time, nodules, haematoma. It helps to resolve complications from thrombosis. However, in this case it is highly advisable to administer it immediately after recognising the first signs of complications. Tissue necrosis could be avoided or become less severe with immediate application of hyaluronidase. Hyaluronidase reduces fibrosis, breaks down the fibrotic tissue trapping fat cells and reduces oedema, it also increases circulation, so it is effective to use for grade 1 and 2 cellulite together with another lipolytic agent and appropriate massage with anti-cellulite cream. Reduces the appearance of hypertrophic scars. Increases absorption of other products.